Short answer
Follow-up testing has two distinct jobs: test-of-cure (did treatment work?) for select situations, and retesting (did reinfection occur?) as routine after bacterial STIs.
Your clinician assigns which applies and when. This guide explains the logic so appointments make sense and none get skipped.
Advertisement
Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.
See Tests & Prices →Test-of-cure: proving eradication where it matters
Most uncomplicated bacterial cases need no test-of-cure. Cure is assumed with adherence.
Exceptions where verification is standard: pregnancy (fetal stakes demand proof), persistent symptoms after therapy (distinguishing failure from reinfection), uncertain adherence (vomiting, missed doses, interactions), alternative regimens used outside the standard path, and M.
genitalium per guidance.
These use precisely timed tests. Not immediate retests, which detect dead organism DNA rather than live infection.
The timing science is detailed in STI Testing Window Periods Explained.
Routine retesting: catching reinfection, not failure
Chlamydia and gonorrhea retesting a few months post-treatment is standard because reinfection rates run high. Overwhelmingly via untreated partners, not drug failure.
Syphilis follows serial blood-titer series over months rather than NAAT.
Trichomoniasis retesting follows current guidance.
These schedules exist because reinfection is common, not because treatment usually fails. A crucial distinction that keeps patients from mistrusting effective therapy.
Partner treatment closing the loop is covered in Should Both Partners Get Tested?.
Monitoring long-term infections
HIV, hepatitis B, and similar chronic infections use monitoring schedules (viral loads, immune markers, liver panels) rather than clearance retests. Confirming sustained control instead.
Herpes and HPV follow symptom- and screening-driven rhythms rather than “all clear” testing.
Each infection’s follow-up answers its own question; applying one infection’s schedule to another’s biology is a common source of confusion that clinicians resolve visit by visit.
Adherence and attendance as treatment
Finish every dose, abstain through the treatment window, bring partners into care, and attend follow-ups even when feeling cured.
The patients who skip retesting are the ones who silently re-spread. Attendance is part of the prescription, not an optional extra.
Calendar every date before leaving the clinic; intentions without dates evaporate under the relief of feeling better.
When to seek care
On the exact schedule given, sooner for returning symptoms, and immediately for new exposures or new partners’ diagnoses.